Phospho-Histone H3 (Thr32) Antibody

What is the biological significance of Histone H3 phosphorylation at Threonine 32?

Histone H3 is one of the core DNA-binding proteins found in the chromatin of all eukaryotic cells. The phosphorylation of Histone H3 at Threonine 32 (Thr32) plays a critical role in several nuclear processes including chromatin remodeling, chromosome condensation, and mitotic progression. This post-translational modification is part of the "histone code" that influences gene expression, DNA repair, DNA replication and chromosomal stability . The N-terminal tail of histone H3 protrudes from the nucleosome core and undergoes various modifications including phosphorylation at specific residues like Thr32, which serves as an important regulatory mechanism during cell division .

How does Phospho-Histone H3 (Thr32) differ from other H3 phosphorylation sites?

Histone H3 contains multiple phosphorylation sites with distinct functions and distribution patterns:

Unlike Thr3 phosphorylation, which becomes restricted to pericentromeric domains during the second meiotic division, Thr32 phosphorylation remains widespread along chromosome arms in all species analyzed . This distinct distribution pattern suggests specialized roles for each phosphorylation site in chromosome dynamics and cell cycle regulation.

What are the optimal storage conditions for Phospho-Histone H3 (Thr32) antibodies?

For maximum stability and activity retention of Phospho-Histone H3 (Thr32) antibodies:

• Store at -20°C for long-term storage

• Avoid repeated freeze-thaw cycles as they can degrade antibody quality

• Most commercial preparations contain preservatives (typically 0.02% sodium azide) and stabilizers (often 50% glycerol)

• Working aliquots can be stored at 4°C for short periods (1-2 weeks)

• When in use, keep antibodies on ice to preserve activity

Following these storage guidelines will help maintain antibody specificity and sensitivity throughout your research project.

What are the recommended applications and dilutions for Phospho-Histone H3 (Thr32) antibodies?

Phospho-Histone H3 (Thr32) antibodies can be used in multiple applications with the following recommended dilutions:

For optimal results, it's advisable to perform a titration experiment to determine the ideal concentration for your specific experimental system and sample type .

How do I optimize Western blot protocols for detecting Phospho-Histone H3 (Thr32)?

For optimal Western blot detection of Phospho-Histone H3 (Thr32):

• Sample preparation:

  • Include phosphatase inhibitors in lysis buffers to prevent dephosphorylation

  • For enrichment, consider acid extraction of histones or nuclear isolation

  • Nocodazole-treated cells serve as excellent positive controls

• Gel electrophoresis:

  • Use high percentage (15-18%) gels to properly resolve the 17 kDa histone proteins

  • Load 10-20 μg of total protein per lane

• Transfer conditions:

  • Use PVDF membranes (0.2 μm pore size) for optimal protein retention

  • Transfer at lower voltage for longer time to ensure complete transfer of small proteins

• Antibody incubation:

  • Block with 5% BSA in TBST (not milk, which contains phosphatases)

  • Incubate primary antibody (1:1000-1:2000) overnight at 4°C

  • Use appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG)

• Detection:

  • Enhanced chemiluminescence provides suitable sensitivity

  • Expect a clean band at approximately 17 kDa

What controls should be included when using Phospho-Histone H3 (Thr32) antibodies?

Proper controls are essential for interpreting results with Phospho-Histone H3 (Thr32) antibodies:

• Positive controls:

  • Nocodazole-treated cell lysates (arrests cells in mitosis, increasing H3 phosphorylation)

  • Mitotic cell extracts (naturally enriched for phosphorylated H3)

• Negative controls:

  • Lambda phosphatase-treated samples (removes phosphorylation)

  • Interphase cell extracts (minimal H3 Thr32 phosphorylation)

  • Secondary antibody-only controls (for immunostaining)

• Specificity controls:

  • Peptide competition assays using phosphorylated vs. non-phosphorylated peptides

  • Immunodepletion controls for polyclonal antibodies

  • IgG isotype controls for immunoprecipitation experiments

• Loading controls:

  • Total Histone H3 antibody (for normalized quantification)

  • Other core histones for comparative analysis

These controls help validate antibody specificity and ensure accurate interpretation of experimental results .

How do distribution patterns of Phospho-Histone H3 (Thr32) vary across different species and cell cycle stages?

Research has revealed significant variation in Phospho-Histone H3 (Thr32) distribution patterns:

These distribution patterns reflect the complex regulatory mechanisms governing chromosome dynamics during cell division and highlight potential functional differences between species with different genome sizes.

What kinases are responsible for Histone H3 Thr32 phosphorylation?

While the specific kinases targeting Histone H3 Thr32 are not definitively established in the provided literature, comparative analysis with other H3 phosphorylation sites provides insights:

• For Thr3 phosphorylation: Haspin kinase has been identified as the primary responsible enzyme

• For Ser10 phosphorylation: Mitogen- and stress-activated kinase 1 (MSK1) and ribosomal subunit protein S6 kinase 2 (RSK2) have been implicated

The kinase(s) responsible for Thr32 phosphorylation likely belong to cell cycle-regulated kinase families such as Aurora kinases, cyclin-dependent kinases (CDKs), or Polo-like kinases (PLKs), given the temporal pattern of this modification during mitosis and meiosis .

Understanding the responsible kinases would enable:

• More targeted experimental designs

• Development of specific inhibitors for functional studies

• Better interpretation of the biological significance of Thr32 phosphorylation

How can I validate the specificity of Phospho-Histone H3 (Thr32) antibodies?

Thorough validation is crucial for ensuring antibody specificity:

• Peptide competition assays:

  • Pre-incubate antibody with phosphorylated Thr32 peptide (should block signal)

  • Use unphosphorylated Thr32 peptide as negative control (should not block signal)

  • Test with peptides phosphorylated at other sites (Thr3, Ser10) to confirm specificity

• Biochemical validation:

  • Perform Western blot analysis (should show single band at 17 kDa)

  • Compare phosphatase-treated vs. untreated samples

  • Use antibodies purified by affinity-chromatography with epitope-specific phosphopeptides

• Cell-based validation:

  • Compare cells in different cell cycle phases (mitotic vs. interphase)

  • Correlate with known temporal patterns of Thr32 phosphorylation

  • Co-localization studies with other mitotic markers

• Additional approaches:

  • Mass spectrometry validation of detected modifications

  • Use of histone H3 mutants (T32A or T32D) if available

  • Cross-validation with multiple antibodies targeting the same epitope

Some commercial antibodies undergo rigorous validation including affinity purification using epitope-specific phosphopeptides with non-phospho specific antibodies removed by chromatography using non-phosphopeptides .

What are potential cross-reactivity issues with Phospho-Histone H3 (Thr32) antibodies?

Researchers should be aware of several potential cross-reactivity issues:

• Recognition of other phosphorylation sites:

  • Histone H3 contains multiple phosphorylation sites (Thr3, Ser10, Thr11, Ser28)

  • Antibodies may recognize similar phosphorylated motifs

• Antibody occlusion phenomenon:

  • "Antibody occlusion resulting from a negative impact of densely distributed multiple modifications has been reported for several antibodies widely used in the chromatin field"

  • Adjacent modifications may interfere with antibody binding

• Species-specific differences:

  • While H3 sequences are highly conserved, subtle species differences may affect antibody recognition

  • Validate antibodies in your specific model organism

• Batch-to-batch variability:

  • Different lots of the same antibody may have different specificity profiles

  • Recombinant antibodies may provide better consistency

To address these issues, manufacturers typically purify antibodies using affinity chromatography with epitope-specific phosphopeptides and remove non-phospho specific antibodies through additional chromatography steps .

How should I design ChIP-seq experiments using Phospho-Histone H3 (Thr32) antibodies?

For optimal ChIP-seq results with Phospho-Histone H3 (Thr32) antibodies:

• Sample preparation:

  • Consider cell synchronization to enrich for mitotic cells (nocodazole treatment)

  • Use freshly prepared chromatin

  • Aim for chromatin fragments of 200-500 bp

• Immunoprecipitation:

  • Use 5 μl of antibody and 10 μg of chromatin (approximately 4 × 10^6 cells) per IP

  • Include appropriate controls:

    • Input DNA (pre-immunoprecipitation)

    • IgG control (same species as primary antibody)

    • Positive control (established histone mark)

• Library preparation and sequencing:

  • Follow standard ChIP-seq library preparation protocols

  • Sequence to adequate depth (20-40 million reads)

  • Include spike-in controls for normalization if comparing conditions

• Data analysis:

  • Use peak calling algorithms suitable for histone modifications

  • Consider the expected broad distribution pattern along chromosome arms

  • Compare with datasets for other histone marks to identify relationships

• Validation:

  • Confirm key findings with ChIP-qPCR

  • Correlate with functional outcomes (gene expression, chromatin accessibility)

This approach has been validated for examining the genomic distribution of Phospho-Histone H3 (Thr32) and its relationship to chromatin structure .

How can Phospho-Histone H3 (Thr32) antibodies be used to study chromosome dynamics?

Phospho-Histone H3 (Thr32) antibodies provide valuable tools for studying chromosome dynamics through several approaches:

• Immunofluorescence microscopy:

  • Track temporal and spatial distribution during cell division

  • Co-stain with other chromosome markers (centromeres, kinetochores)

  • Observe chromosome condensation and segregation

  • Typical dilutions range from 1:50 for immunohistochemistry to 1:3200 for immunofluorescence

• Live-cell imaging:

  • Combine with fluorescently-tagged histones to track dynamics

  • Monitor chromosome movements in real-time

• Cell cycle analysis:

  • Use flow cytometry (1:200 dilution) to quantify Thr32 phosphorylation

  • Correlate with cell cycle phase markers

  • Detect mitotic cells in heterogeneous populations

• High-resolution approaches:

  • Super-resolution microscopy to visualize detailed chromosome structure

  • Correlate Thr32 phosphorylation with specific chromosome domains

Research has shown that in meristematic cells, Thr32 phosphorylation begins in prophase and persists until late anaphase or anaphase, depending on the species , making these antibodies excellent tools for tracking mitotic progression.

How do I troubleshoot weak or non-specific signals when using Phospho-Histone H3 (Thr32) antibodies?

When encountering weak or non-specific signals, consider these troubleshooting strategies:

• For weak signals:

  • Increase antibody concentration (try 1:500 instead of 1:1000)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Enrich for mitotic cells (nocodazole treatment) to increase target abundance

  • Use signal enhancement systems (TSA amplification for immunostaining)

  • Optimize protein extraction methods for histones (acid extraction)

  • Ensure adequate blocking to improve signal-to-noise ratio

• For non-specific signals:

  • Increase washing duration and stringency

  • Use alternative blocking reagents (BSA instead of milk for phospho-epitopes)

  • Pre-absorb antibody with non-specific proteins

  • Decrease antibody concentration if background is high

  • Try alternative detection systems (fluorescent vs. chemiluminescent)

  • Consider using more specific monoclonal antibodies

• For Western blot issues:

  • Ensure phosphatase inhibitors are included in sample preparation

  • Use freshly prepared samples

  • Optimize gel percentage (15-18%) for better resolution of the 17 kDa band

  • Consider using PVDF membranes instead of nitrocellulose for better protein retention

• For immunostaining issues:

  • Optimize fixation methods (paraformaldehyde vs. methanol)

  • Try different antigen retrieval techniques

  • Reduce autofluorescence with appropriate quenching agents

  • Use different secondary antibodies to reduce background

Following these strategies should help resolve most technical issues encountered when using Phospho-Histone H3 (Thr32) antibodies .

How are Phospho-Histone H3 (Thr32) antibodies being used in cancer research?

Phospho-Histone H3 antibodies are increasingly valuable in cancer research:

• Mitotic index determination:

  • Phospho-Histone H3 (at various sites including Thr32) serves as a specific marker for mitotic cells

  • "Determination of the mitotic index using pH3 has been reported to be of prognostic significance in breast cancer, melanoma and meningiomas"

  • Provides more accurate proliferation assessment than other markers

• Tumor grading:

  • "pH3 immunostaining may also provide an accurate proliferation potential which can be relevant to tumor grading"

  • Helps distinguish between low and high-grade malignancies

• Treatment response monitoring:

  • Assessment of anti-mitotic drug efficacy

  • Evaluation of cell cycle arrest in response to therapies

• Diagnostic applications:

  • Identification of mitotically active cells in tissue samples

  • Differentiation between reactive conditions and neoplastic processes

While these applications have been established primarily with phospho-Histone H3 antibodies targeting other residues (particularly Ser10), the specific role of Thr32 phosphorylation in cancer biology represents an emerging area for investigation.

What novel techniques are being developed using Phospho-Histone H3 (Thr32) detection?

Innovative approaches utilizing Phospho-Histone H3 (Thr32) detection include:

• Homogeneous Time-Resolved Fluorescence (HTRF) assays:

  • "The phospho-Histone H3 (Thr3) assay measures Histone H3 when phosphorylated at Thr3. Contrary to Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis or transfer"

  • Similar approaches are being developed for Thr32 detection

  • Enables high-throughput screening applications

• Engineered sortase transpeptidase techniques:

  • "Engineered sortase transpeptidase, cW11, that displays highly favorable properties for introducing scarless H3 tails onto nucleosomes"

  • Allows for site-specific modification of histones for functional studies

  • Can be used to introduce specific phosphorylation marks including Thr32

• Multi-parameter flow cytometry:

  • Combines Phospho-Histone H3 detection with other cellular markers

  • Enables complex analysis of cell populations and their cell cycle status

  • Useful for understanding tumor heterogeneity

• Mass spectrometry-based approaches:

  • Quantitative analysis of histone modifications including Thr32 phosphorylation

  • Can detect multiple modifications simultaneously

  • Provides unbiased assessment of modification patterns